SEC Form 4 · accession 0001596771-18-000076
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian T Griffin
Officer — Chairman and CEO · Director
Period of report
Jun 4, 2018
Accepted (ET)
Jun 6, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 4, 2018 | A | 33,716 | $0.00 | A | 33,716 | D | |
| Common StockF1,F3 | Jun 4, 2018 | A | 124,875 | $0.00 | A | 158,591 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common StockF4 | $24.29 | Jun 4, 2018 | A | 81,351 | A | — | Jun 4, 2028 | Common Stock | 81,351 | 81,351 | D |
Explanation of responses
- F1The restricted stock units ("RSUs") represent an inducement award of stock to the reporting person in connection with his appointment as CEO and Chairman.
- F2One-third of the RSUs will vest on each of the first, second and third anniversary of the grant date.
- F3The RSUs will vest on the first anniversary of the grant date, provided the vesting of these RSUs may be accelerated based on the achievement of a specified stock price performance goal.
- F4Represents an inducement award of stock options to the reporting person in connection with his appointment as CEO and Chairman. One-third of the options will vest on each of the first, second and third anniversary of the grant date.